nafamostat has been researched along with ng-nitroarginine methyl ester in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chekir, C; Kamada, Y; Konishi, H; Kudo, T; Nakatsuka, M; Noguchi, S | 1 |
| Chekir, C; Hiramatsu, Y; Kamada, Y; Konishi, H; Nakatsuka, M; Noguchi, S; Sasaki, A | 1 |
2 other study(ies) available for nafamostat and ng-nitroarginine methyl ester
| Article | Year |
|---|---|
Nafamostat mesilate suppresses NF-kappaB activation and NO overproduction in LPS-treated macrophages.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzamidines; Cell Line; Cell Nucleus; Depression, Chemical; Electrophoretic Mobility Shift Assay; Enzyme Induction; Enzyme Inhibitors; Guanidines; I-kappa B Proteins; Lipopolysaccharides; Macrophages; Mice; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Transcription, Genetic | 2003 |
Advanced glycation end products induce secretion of chemokines and apoptosis in human first trimester trophoblasts.
Topics: Apoptosis; Benzamidines; Cells, Cultured; Chemokine CCL3; Chemokine CCL4; Chemokine CCL5; Chemokines; Chorionic Gonadotropin; Chorionic Villi; Drug Combinations; Enzyme Inhibitors; Female; Glycation End Products, Advanced; Guanidines; Humans; Macrophage Inflammatory Proteins; NG-Nitroarginine Methyl Ester; Pregnancy; Pregnancy Trimester, First; Protease Inhibitors; Protein Isoforms; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Serum Albumin, Bovine; Trophoblasts | 2004 |